Merck & Co. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number increased by 0.3% to $12.24M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.3%, from $12.20M to $12.24M. Over 4 years (FY 2021 to FY 2025), Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shows a downward trend with a -9.0% CAGR.
An increase reflects a growing commitment to long-term equity-based compensation for the workforce.
This represents the number of stock options that are either currently vested or expected to vest based on service requir...
This is a standard disclosure for assessing the long-term dilution impact of employee stock option plans.
other_share_based_compensation_arrangement_by_share_base_25b35b| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $17.83M | $13.20M | $13.12M | $12.20M | $12.24M |
| QoQ Change | — | -26.0% | -0.6% | -7.0% | +0.3% |
| YoY Change | — | -26.0% | -0.6% | -7.0% | +0.3% |